DOCSLIB.ORG
Explore
Sign Up
Log In
Upload
Search
Home
» Tags
» Vorozole
Vorozole
By Exemestane, a Novel Irreversible Aromatase Inhibitor, in Postmenopausal Breast Cancer Patients1
Fast Three Dimensional Pharmacophore Virtual Screening of New Potent Non-Steroid Aromatase Inhibitors
Preliminary Data from Ongoing Adjuvant Aromatase Inhibitor Trials I
Aromatase and Its Inhibitors: Significance for Breast Cancer Therapy † EVAN R
Aromatase Inhibitors and Their Use in the Sequential Setting
Initial Studies with 11C-Vorozole PET Detect Overexpression of Intratumoral Aromatase in Breast Cancer
Ehealth DSI [Ehdsi V2.2.2-OR] Ehealth DSI – Master Value Set
Aspects of the Usage of Antineoplastic and 1Mmunomodulating Agents in a Section of the Private Health Care Sector
Aromatase Inhibitors in the Treatment and Prevention of Breast Cancer
(12) United States Patent (10) Patent No.: US 8,795,629 B2 Kim Et Al
Use of Aromatase Inhibitors in Breast Carcinoma
In Vivo Measurement of Aromatase Inhibition by Letrozole (CGS 20267) in Postmenopausal Patients with Breast Cancer
Drug and Hormone Interactions of Aromatase Inhibitors
Anastrozole Is Superior to Tamoxifen As First-Line Therapy for Advanced
Are Differences in the Available Aromatase Inhibitors and Inactivators Significant?
Role of Aromatase Inhibitors in Advanced Breast Cancer
Initial Studies with 11C-Vorozole Positron Emission Tomography Detect Over-Expression
Dual Aromatase–Sulfatase Inhibitors (Dasis) Were Separated by Chiral HPLC and Their Absolute Configura- Have Been Reported
Top View
Chemical Structure-Related Drug-Like Criteria of Global Approved Drugs
Discovery of Novel Aromatase Inhibitors Using a Homogeneous Time-Resolved Fluorescence Assay
WO 2016/176208 Al 3 November 2016 (03.11.2016) P O P C T
Reinvestigation of the Synthesis and Evaluation Of
Australian Statistics on Medicines 2009
Pdf/2009-10/Firmagon - Ct-6725.Pdf 58
Aromatase Inhibitors in Pediatrics Jan M
Exemestane, a New Steroidal Aromatase Inhibitor of Clinical Relevance$
Harmonized Tariff Schedule of the United States (2006) (Rev
Neurogenesis Via Modulation of the Muscarinic Receptors
Aromatase Inhibitors and Their Use in the Sequential Setting
Anastrozole ('Arimidex')
Medication Use for the Risk Reduction of Primary Breast Cancer in Women: a Systematic Review for the U.S
PET of Aromatase in Gastric Parietal Cells Using 11C-Vorozole
Aromatase Inhibitors As Potential Cancer Chemopreventives
[Ehdsi V3.0.0-RC1] Ehealth DSI – Master Value Set Catalogue
Aromatase Inhibitors for Treatment of Advanced Breast Cancer in Postmenopausal Women (Review)
Advances in Aromatase Inhibition: Clinical Efficacy and Tolerability in the Treatment of Breast Cancer
ATC Code Title